SETD7 and colorectal carcinoma: The authors supported their conclusions by analysis of SETD7 expression in the GSE39582 dataset (443 CRC samples) using the Syntarget tool (bioprofiling.de) to show that high co-expression of SETD7 and KHDRBS1 (Sam68) significantly correlated with better overall survival of CRC patients, while patients with low SETD7 and high KHDRBS1 expression showed poor OS.